Align Technology Welcomes Two New Members to its Board

Align Technology Inc.’s has appointed Mojdeh Poul and Kevin Conroy to its Board of Directors.
 
“I am pleased to welcome Mojdeh and Kevin to Align’s Board of Directors,” Align Technology President/CEO Joe Hogan said. “Each brings extensive experience across the healthcare industry that complements the depth and breadth of Align’s board. Mojdeh has led global businesses and operations in large multinational organizations and has deep expertise in business strategy and transformation, as well as commercial excellence. Kevin has an exceptional track-record for growth and his technical and clinical expertise, combined with a focus on digitally innovative solutions, have delivered amazing customer experiences. Mojdeh and Kevin are both outstanding additions to our board and I am confident that their knowledge and insights will benefit Align as we continue to drive the evolution of digital orthodontics and restorative dentistry globally.”
 
Poul was most recently executive vice president and group president of 3M Health Care, where she was responsible for its global P&L, strategy, research and development, manufacturing, and commercial operations. During her tenure at 3M, Poul held leadership roles, including executive vice president of Safety & Graphics Business Group, president of 3M Canada, and president of two divisions within the 3M Health Care Business Group. Prior to 3M, Poul held several leadership roles of increasing responsibility with Medtronic and Boston Scientific Corp. Before that, Poul held engineering positions with General Electric Plastics. Poul currently serves as a director of iRhythm Technologies and Stanley Black and Decker. 

Poul earned an MBA from the University of North Carolina, Chapel Hill, and M.Eng. and bachelor of science degrees in mechanical engineering from the University of Louisville.
 
Conroy is president, CEO, and board chairman of cancer diagnostics firm Exact Sciences Corporation. He became CEO in 2009 and chairman in 2014, leading Exact Sciences through the development and commercialization of its noninvasive colorectal cancer screening test, Cologuard, which became the first medical device or diagnostic to receive simultaneous U.S. Food and Drug Administration approval and national Medicare coverage. Prior to Exact Sciences, Conroy was CEO and president of Third Wave Technologies, held leadership positions at GE Healthcare, and practiced intellectual property law in private practice. Conroy formerly served as a director of Adaptive Biotechnologies Corporation, Epizyme Inc., and SomaLogic Inc.

Conroy earned a J.D. degree from the University of Michigan Law School and a B.S.E. degree in electrical engineering from Michigan State University.
 
Align’s board is comprised of 10 directors, four of whom will have been appointed in the last six years.
 
Align Technology designs and manufactures the Invisalign System, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for more than 252,000 doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 26 years, Align has helped doctors treat 16.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform, its integrated suite of proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and labs/partners.